US Bancorp’s Rockwell Medical RMTI Stock Holding History

US Bancorp’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3	Closed	-$2K	–	3680
2018 Q1	$2K	Buy	+3	New	+$1.89K	﹤0.01%	3498
2016 Q4	–	Sell	-168	Closed	-$124K	–	3620
2016 Q3	$124K	Buy	+168	New	+$136K	﹤0.01%	1983

Other funds holding RMTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BKS Advisors Southfield, Michigan $249M AUM 14.37% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

US Bancorp's RMTI Position: Q2 2018 in Review

US Bancorp sold out of Rockwell Medical (RMTI) in Q2 2018, closing a stake of 3 shares — an estimated $2K sold.

US Bancorp first reported a position in RMTI in Q3 2016 and held it in 2 quarters. The position peaked at $124K in Q3 2016. 87 funds tracked by Wall St. Rank hold RMTI as of Q2 2018.

US Bancorp reported no remaining Rockwell Medical position as of Q2 2018 after selling out during the quarter.
US Bancorp sold 3 Rockwell Medical shares in Q2 2018, an estimated $2K.
US Bancorp first reported a position in Rockwell Medical in Q3 2016 and held it in 2 quarters.
US Bancorp's Rockwell Medical position peaked at $124K in Q3 2016.
87 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2018.

Based on US Bancorp's 13F filing for Q2 2018, filed 8 Aug 2018.